Group B streptococcal β-hemolysin induces nitric oxide production in murine macrophages

Journal of Infectious Diseases

Volumn 182, Issue 1, 2000, Pages 150-157

  Ring, Axel ^a,c   Braun, Johann S ^a,e   Nizet, Victor ^d   Stremmel, Wolfgang ^c   Shenep, Jerry L ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOLYSIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HEMOLYSIS; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; STREPTOCOCCUS AGALACTIAE; TRANSPOSON;

ANIMALS; BACTERIAL PROTEINS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INDUCTION; HEMOLYSIN PROTEINS; HEMOLYSIS; INTERFERON TYPE II; MACROPHAGES; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 0033928019     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315681     Document Type: Article

References (51)

1. 1. Baker CJ, Edward MS. Group B streptococcal infections. In: Remington J, Klein JO, eds. Infectious diseases of the fetus and newborn infant, 4th ed. Philadelphia: WB Saunders, 1995:980-1054.
2. 2. Weiser JN, Rubens CE. Transposon mutagenesis of group B streptococcus beta-hemolysin biosynthesis. Infect Immun 1987;55:2314-6.
3. 3. Rubens CE, Wessels MR, Heggen LM, Kasper DL. Transposon mutagenesis of type III group B streptococcus: correlation of capsule expression with virulence. Proc Natl Acad Sci USA 1987;84:7208-12.
4. 4. Nizet V, Gibson RL, Chi EY, Framson PE, Hulse M, Rubens CE. Group B streptococcal beta-hemolysin expression is associated with injury of lung epithelial cells. Infect Immun 1996;64:3818-26.
5. 5. Gibson RL, Nizet V, Rubens CE. Group B streptococcal β-hemolysin promotes injury of lung microvascular endothelial cells. Pediatr Res 1999; 45:626-34.
6. 6. Nizet V, Kim KS, Stins M, et al. Invasion of brain microvascular endothelial cells by group B streptococci. Infect Immun 1997;65:5074-81.
7. 7. Griffiths BB, Rhee H. Effects of haemolysins of groups A and B streptococci on cardiovascular system. Microbios 1992;69:17-27.
8. 8. Evans T, Carpenter A, Kinderman H, Cohen J. Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock 1993;41: 77-81.
9. 9. Spack L, Havens PL, Griffith OW. Measurements of total plasma nitrite and nitrate in pediatric patients with the systemic inflammatory response syndrome. Crit Care Med 1997;25:1071-8.
10. 10. Bucher M, Ittner KP, Zimmermann M, Wolf K, Hobhahn J, Kurtz A. Nitric oxide synthase isoform III gene expression in rat liver is up-regulated by lipopolysaccharide and lipoteichoic acid. FEBS Lett 1997;412:511-4.
11. 11. Wong JM, Billiar TR. Regulation and function of inducible nitric oxide synthase during sepsis and acute inflammation. Adv Pharmacol 1995;34: 155-70.
12. 12. Szabó C, Thiemermann C. Regulation of the expression of the inducible isoform of nitric oxide synthase. Adv Pharmacol 1995;34:113-53.
13. 13. Geng Y, Maier R, Lotz M. Tyrosine kinases are involved with the expression of inducible nitric oxide synthase in human articular chondrocytes. J Cell Physiol 1995;163:545-54.
14. 14. Okuda S, Kanda F, Kawahara Y, Chihara K. Regulation of inducible nitric oxide synthase expression in rat skeletal muscle cells. Am J Physiol 1997;272:C35-40.
15. 15. Oddis CV, Simmons RL, Hattler BG, Finkel MS. Protein kinase A activation is required for IL-1 induced nitric oxide production by cardiac myocytes. Am J Physiol 1996;271:C429-34.
16. 16. Kleinert H, Euchenhofer C, Ihrig-Biedert I, Förstermann U. In murine 3T3 fibroblasts, different second messenger pathways resulting in the induction of NO synthase II (iNOS) converge in the activation of transcription factor NF-kB. J Biol Chem 1996;271:6039-44.
17. 17. Singh K, Balligand J, Fischer TA, Smith TW, Kelly RA. Regulation of cytokine-inducible nitric oxide synthase in cardiac myocytes and microvascular endothelial cells. J Biol Chem 1996;271:1111-7.
18. 18. Kitamura Y, Takahashi H, Nomura Y, Taniguchi T. Possible involvement of Janus kinase Jak2 in interferon-γ induction of nitric oxide synthase in rat glial cells. Eur J Pharmacol 1996;306:297-306.
19. 19. Milbourne EA, Bygrave FL. Does nitric oxide play a role in liver function? Cell Signal 1995;7:313-8.
20. 13. J Biol Chem 1996;271:7412-5.
21. 21. Kilbourn RG, Szabó C, Traber DL. Beneficial versus detrimental effects of nitric oxide synthase inhibitors in circulatory shock: lessons learned from experimental and clinical studies. Shock 1997;7:235-46.
22. 22. Suttorp N, Fuhrmann M, Tannert-Otto S, Grimminger F, Bhakdi S. Pore-forming bacterial toxins potently induce release of nitric oxide in porcine endothelial cells. J Exp Med 1993;178:337-41.
23. 23. Schütte H, Mayer K, Gessler T, et al. Nitric oxide biosynthesis in an exotoxin-induced septic lung model. Am J Respir Crit Care Med 1998;157:498-504.
24. 24. Goodrum KJ, McCormick LL, Schneider B. Group B streptococcus-induced nitric oxide production is CR3 (CD 11b/CD18) dependent. Infect Immun 1994;62:3102-7.
25. 25. Braun JS, Novak R, Gao G, Murray PJ, Shenep J. Pneumolysin, a protein toxin from Streptococcus pneumoniae, induces nitric oxide production from macrophages. Infect Immun 1999;67:3750-6.
26. 26. Alouf JE, Geoffroy C. The family of the antigenically-related, cholesterol-binding ('sulphydryl-activated') cytolytic toxins. In: Alouf JE, Freer JH, eds. Sourcebook of bacterial protein toxins. London: Academic Press, 1991:147-86.
27. 27. Lacks S, Hotchkiss RD. A study of the genetic material determining an enzyme activity in pneumococcus. Biochem Biophys Acta 1960;39:508-17.
28. 28. Wessels MR, Benedi V, Kasper DL, Heggen LM, Rubens CE. Type III capsule and virulence of group B streptococci. In: Dunny GM, Cleary PP, McKay LL eds. Genetics and molecular biology of streptococci, lactococci, and enterococci. Washington, DC: American Society for Microbiology, 1991: 219-23.
29. 29. Marchlewicz BA, Duncan JL. Properties of a hemolysin produced by group B streptococci. Infect Immun 1980;30:805-13.
30. 30. Hevel J, Marletta M. Nitric-oxide synthase assays. Methods Enzymol 1994;233:250-8.
31. 31. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
32. 32. Pang L, Sawada T, Decker SJ, Saltiel AR. Inhibition of MAP kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J Biol Chem 1995;270:13585-8.
33. 33. Hwang D, Jang BC, Yu G, Boudreau M. Expression of mitogen-inducible cyclooxygenase induced by lipopolysaccharide. Biochem Pharmacol 1997;54:87-96.
34. 34. Spellerberg B, Pohl B, Haase G, Martin S, Weber-Heynemann J, Lütticken R. Identification of genetic determinants for the hemolytic activity of Streptococcus agalactiae by ISS1 transposition. J Bacteriol 1999;181: 3212-9.
35. 35. Pritzlaff CA, Chang JCW, Tamura GS, Rubens CE, Nizet V. Genetic basis of the group B streptococcal β-hemolysin/cytolysin. In: Martin DR, Tagg JR, eds. Streptococci and streptococcal diseases - entering the new millennium: proceedings of the 14th Lancefield International Symposium on Streptococci and Streptococcal Diseases (Auckland, NZ). Auckland, NZ: Securacopy (in press).
36. 36. Lannering B, Larsson LE, Rogas J, et al. Early onset group B streptococcal disease. Seven year experience and clinical scoring system. Acta Paediatr Scand 1983;72:597-602.
37. 37. Payne NR, Burke BA, Day DL, Christenson PD, Thompson TR, Ferrieri P. Correlation of clinical and pathologic findings in early onset neonatal group B streptococcal infection with disease severity and prediction of outcome. Pediatr Infect Dis J 1988;7:836-47.
38. 38. Kengatharan M, De Kimpe SJ, Thiemermann C. Analysis of the signal transduction in the induction of nitric oxide synthase by lipoteichoic acid in macrophages. Br J Pharmacol 1996;117:1163-70.
39. 39. Hattor Y, Kasai K, Akimoto K, Thiemermann C. Induction of NO synthesis by lipoteichoic acid from Staphylococcus aureus in J774 macrophages: involvement of a CD14-dependent pathway. Biochem Biophys Res Commun 1997;233:375-9.
40. 40. De Kimpe SJ, Kengatharan M, Thiemermann C. The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure. Proc Natl Acad Sci USA 1995;92:10359-63.
41. 41. Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-kB/Rel in induction of nitric oxide synthase. J Biol Chem 1994;269:4705-8.
42. 42. Read MA, Cordle SR, Veach RA, Carlisle CD, Hawiger J. Cell-free pool of CD-14 mediates activation of transcription factor NF-kB by lipopolysaccharide in human endothelial cells. Proc Natl Acad Sci USA 1993;90: 9887-91.
43. 43. Iwasata T, Uehara Y, Graves L, Rachie N, Bonsztyk K. Herbimycin A blocks IL-1 induced NF-kB DNA-binding activity in lymphoid cell lines. FEBS Lett 1992;298:240-4.
44. 44. Paul A, Plevin R. Cell signalling events involved in mediating the induction of nitric oxide synthase in macrophages and vascular smooth muscle cells. Biochem Soc Trans 1995;23:1029-33.
45. 45. Stefanova I, Corcoran ML, Horak EM, Wahl LM, Bolen JB, Horak ID. Lipopolysaccharide induces activation of CD14-associated protein tyrosine kinase p53/56lyn. J Biol Chem 1993;268:20725-8.
46. 46. Liu KM, Herrera P, Brownsey RW, Reiner NE. CD14-dependent activation of protein kinase C and mitogen-activated protein kinases (p42 and p44) in human monocytes treated with bacterial lipopolysaccharide. J Immunol 1994;153:2642-52.
47. 47. Hambleton J, Weinstein SL, Lem L, De Franco AL. Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. Proc Natl Acad Sci USA 1996;93:2774-8.
48. 48. Han J, Lee JD, Tobias PS, Ulevitch RJ. Endotoxin induces rapid protein tyrosine phosphorylation in 70Z/3 cells expressing CD14. J Biol Chem 1993;268:25009-14.
49. 49. Han J, Lee JD, Bibbs L, Ulevitch RJ. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 1994;265:808-11.
50. 50. Sanghera JS, Weinstein SL, Aluwalia M, Girn J, Pelech SL. Activation of multiple proline-directed kinases by bacterial lipopolysaccharide in murine macrophages. J Immunol 1996;156:4457-65.
51. 51. Li JD, Feng W, Gallup M, et al. Activation of NF-kB via a Src-dependent Ras-MAPK-pp90rsk pathway is required for Pseudomonas aeruginosa-induced mucin overproduction in epithelial cells. Proc Natl Acad Sci USA 1998;95:5718-23.